AN2 Therapeutics, Inc.

Q2 2025 13F Holders

Symbol
ANTX
CUSIP
037326105
Type
Equity
Class
COM
Num filings
38
Total reported value, excl. options
$8.78 M
Manager Report Date Value ($000) Shares Option Type